Wolverine Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.82M | Buy |
+7,411
| New | +$7.51M | 0.07% | 270 |
|
|
2025
Q4 | – | Sell |
-1,895
| Closed | -$1.81M | – | 1778 |
|
|
2025
Q3 | $1.45M | Sell |
1,895
-3,475
| -65% | -$2.59M | 0.01% | 648 |
|
|
2025
Q2 | $4.19M | Buy |
5,370
+5,154
| +2,386% | +$4.01M | 0.04% | 371 |
|
|
2025
Q1 | $178K | Sell |
216
-393
| -65% | -$327K | ﹤0.01% | 1026 |
|
|
2024
Q4 | $470K | Buy |
+609
| New | +$504K | ﹤0.01% | 881 |
|
|
2023
Q4 | – | Sell |
-8,864
| Closed | -$5.17M | – | 1902 |
|
|
2023
Q3 | $4.76M | Buy |
+8,864
| New | +$4.57M | 0.05% | 326 |
|
|
2023
Q2 | – | Sell |
-3,449
| Closed | -$1.45M | – | 1874 |
|
|
2023
Q1 | $1.18M | Buy |
+3,449
| New | +$1.16M | 0.01% | 645 |
|
|
2021
Q4 | – | Sell |
-699
| Closed | -$177K | – | 2142 |
|
|
2021
Q3 | $161K | Sell |
699
-1,072
| -61% | -$265K | ﹤0.01% | 1207 |
|
|
2021
Q2 | $406K | Sell |
1,771
-793
| -31% | -$159K | ﹤0.01% | 985 |
|
|
2021
Q1 | $479K | Buy |
2,564
+2,272
| +778% | +$444K | ﹤0.01% | 925 |
|
|
2020
Q4 | $49K | Buy |
+292
| New | +$43.6K | ﹤0.01% | 1333 |
|
|
2019
Q4 | – | Sell |
-536
| Closed | -$59K | – | 1459 |
|
|
2019
Q3 | $59K | Buy |
+536
| New | +$59.7K | ﹤0.01% | 1194 |
|
|
2018
Q1 | – | Sell |
-177
| Closed | -$14K | – | 1572 |
|
|
2017
Q4 | $14K | Buy |
+177
| New | +$15.1K | ﹤0.01% | 1355 |
|
|
2017
Q2 | – | Sell |
-2,550
| Closed | -$208K | – | 1376 |
|
|
2017
Q1 | $214K | Sell |
2,550
-23,100
| -90% | -$1.85M | ﹤0.01% | 853 |
|
|
2016
Q4 | $1.89M | Sell |
25,650
-24,050
| -48% | -$1.79M | 0.02% | 415 |
|
|
2016
Q3 | $3.99M | Sell |
49,700
-10,100
| -17% | -$808K | 0.06% | 286 |
|
|
2016
Q2 | $4.71M | Hold |
59,800
| – | – | 0.07% | 266 |
|
|
2016
Q1 | $4.31M | Buy |
59,800
+19,000
| +47% | +$1.44M | 0.12% | 176 |
|
|
2015
Q4 | $3.44M | Sell |
40,800
-21,500
| -35% | -$1.78M | 0.07% | 233 |
|
|
2015
Q3 | $5.21M | Buy |
62,300
+17,200
| +38% | +$1.45M | 0.12% | 160 |
|
|
2015
Q2 | $3.77M | Sell |
45,100
-14,000
| -24% | -$1.07M | 0.09% | 200 |
|
|
2015
Q1 | $4.29M | Buy |
59,100
+59,095
| +1,181,900% | +$4.21M | 0.09% | 180 |
|
|
2014
Q4 | $0 | Buy |
+5
| New | +$337 | ﹤0.01% | 2366 |
|
|
2014
Q2 | – | Sell |
-13,860
| Closed | -$827K | – | 2444 |
|
|
2014
Q1 | $815K | Sell |
13,860
-8,600
| -38% | -$480K | 0.02% | 460 |
|
|
2013
Q4 | $1.15M | Buy |
+22,460
| New | +$1.12M | 0.02% | 475 |
|
|
2013
Q3 | – | Sell |
-8,060
| Closed | -$422K | – | 2793 |
|
|
2013
Q2 | $395K | Buy |
+8,060
| New | +$439K | 0.01% | 831 |
|
Other funds holding LLY
VCM
VPM
Wolverine Asset Management's LLY Position: Q1 2026 in Review
Wolverine Asset Management opened a new position in Eli Lilly (LLY) in Q1 2026: 7,411 shares worth $6.82M. The stake represents 0.07% of the portfolio and ranks #270 among its holdings. This is a return to the name: Wolverine Asset Management previously reported a position in LLY as recently as Q3 2025.
Wolverine Asset Management first reported a position in LLY in Q2 2013 and has held it in 26 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Wolverine Asset Management held 7,411 shares of Eli Lilly worth $6.82M as of Q1 2026.
- Eli Lilly was a new Wolverine Asset Management position in Q1 2026.
- Eli Lilly made up 0.07% of Wolverine Asset Management's portfolio in Q1 2026, its #270 holding.
- Wolverine Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 26 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.